Genetic Evidence for Causal Relationships between Plasma Eicosanoid Levels and Cardiovascular Disease

Area of Science:

• Biochemistry
• Genetics
• Cardiology

Background:

• Cardiovascular diseases (CVD) are leading causes of global mortality and disability.
• Eicosanoids, bioactive metabolites of arachidonic acid, have complex roles in CVD, with both beneficial and detrimental effects.
• The direct causal link between eicosanoid levels and CVD risk has remained unclear.

Purpose of the Study:

• To investigate the potential genetic causal relationship between plasma eicosanoid levels and the risk of developing cardiovascular diseases.
• To leverage genetic variants associated with eicosanoid levels to infer causality.

Main Methods:

• Utilized a two-sample Mendelian randomization (MR) analysis.
• Selected six single nucleotide polymorphisms (SNPs) strongly associated with plasma eicosanoid levels.
• Employed summary-level data for various cardiovascular diseases from public genome-wide association studies.

Main Results:

• Plasma eicosanoid levels showed inverse correlations with several cardiovascular conditions.
• Significant associations were found for unstable angina pectoris, myocardial infarction, ischemic stroke, transient ischemic attack, heart failure, and pulmonary embolism.
• The study identified a genetic causal link between elevated plasma eicosanoid levels and increased risk for these cardiovascular diseases.

Conclusions:

• The findings provide strong genetic evidence supporting a causal relationship between higher plasma eicosanoid levels and elevated cardiovascular disease risk.
• This research suggests that targeting eicosanoid pathways could be a potential therapeutic strategy for managing cardiovascular diseases.